Comprehensive mobile app to support diet, nutrition, and activity for people with cancer
Official title: Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity
Run by Montefiore Medical Center · NCT06860425 · Data updated 2026-11-12
This project will test whether a smartphone app called RestoreMe can help people receiving curative-intent radiation for certain cancers use healthier diet, nutrition, and activity habits during treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Montefiore Medical Center Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (The Bronx, New York) |
| Status | Recruiting |
| Started | February 28, 2023 |
| Main results expected | March 2027 |
| Study ends | March 2027 |
| Registry record updated | February 24, 2026 |
| Trial ID | NCT06860425 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with invasive brain, head and neck, lung, breast, prostate, gastrointestinal, or gynecologic cancers planned for or receiving curative-intent radiation who have a smartphone, read/write English, and have ECOG 0–2.
✕Probably not a fit
Patients with metastatic disease, those receiving only palliative treatment, people without a compatible smartphone or who cannot read English, and patients with poorly controlled diabetes are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with specified invasive cancers who are planned for or receiving curative-intent radiation therapy will download and use the RestoreMe mobile application during their treatment course. The app delivers educational content, messaging, and tracking tools for diet, nutrition, and physical activity while usage and engagement are recorded. The study focuses on whether patients consistently use the app throughout treatment and whether it changes patient behaviors and understanding about health. Participants must have a smartphone, read and write English, and meet ECOG performance status 0–2, while metastatic or palliative patients are excluded.
Why it matters
Potential benefit: If successful, the app could help patients maintain healthier nutrition and activity habits during radiation therapy and improve their overall treatment experience and recovery.
How similar studies have gone: Previous m-health work, including an RCT of an AI pain-monitoring app in oncology that reduced pain and hospitalizations, shows mobile apps can be effective, though apps specifically targeting diet and activity in curative-intent radiation are less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of invasive malignancy of the brain, head and neck region, lung, breast (DCIS and invasive disease allowed), prostate, gastrointestinal system or gynecological region * Planned to receive, or have received, radiation therapy treatment with curative intent * Note: Patients undergoing systemic therapy are eligible * Note: Any dose/fractionation of curative-intent radiation therapy is eligible * Patients must have a smartphone or other device with the ability to receive text messages, download and use mobile applications * Eastern Cooperative Oncology Group (ECOG) performance status 0-2 * Ability to read and write in English * Provide written informed consent to participate in the study o NOTE: Patients enrolled on another clinical trial are eligible Exclusion Criteria: * Metastatic cancer * Undergoing treatment with palliative intent * Poorly controlled diabetes (defined as fasting glucose level \> 200 mg/dL despite attempts to improve glucose control by fasting duration and adjustment of medications) * Uncontrolled hypertension * Any medical condition requiring fluid restriction or nutrient restrictions
Where it's running
-
Montefiore Einstein Comprehensive Cancer Center
The Bronx, New York, United States Recruiting
Study contacts
- Principal investigator: Rafi Kabarriti, MD — Montefiore Medical Center
- Study coordinator: Rafi Kabarriti, MD
- Email: rkabarri@montefiore.org
- Phone: 914-629-7743
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Diosmin/Hesperidin to Protect Kidneys in Platinum Chemotherapy
This study tests whether taking diosmin and hesperidin helps protect the kidneys of cancer patients who are receiving platinum-based chemotherapy.
-
Promoting Walking for Older Adults with Friendly Messages and Step Reminders
This study tests whether friendly affective messages and step-tracking reminders can help adults aged 65–74 walk more, by linking memories of their past selves to their present and future actions.
-
Reminders to help you log your meals
This study tests whether loss-framed or streak-feedback reminders help adults 45 and older in Switzerland log meals with a phone app more often than neutral reminders.
-
Early pregnancy lifestyle patterns and glucose changes in a TOFFFY sub-study
This study tests whether daily patterns like sleep, activity, and meal timing in early pregnancy affect glucose levels and the risk of gestational diabetes, using CGM and wearable data in pregnant women in Singapore.
-
Tibetree topical herbal plasters for people using opioids for cancer pain
This trial will try Tibetree topical herbal plasters together with prescribed opioids to see if they reduce localized cancer-related pain for adults who are currently taking short-term oral opioids.
-
Education and a smartphone app to help organ transplant patients manage life, meds, and symptoms
A smartphone app plus teaching materials are tested to see if they improve quality of life and adherence to immunosuppressive therapy for adults who have had a liver or kidney transplant.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.